Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

zuChem Inc
Profile last edited on: 12/20/2019      CAGE: 46JJ0      UEI: LHZKXV13TLJ7

Business Identifier: Glycochemicals: Custom synthesis of rare and modified sugars for pharmaceutical applications
Year Founded
2001
First Award
2005
Latest Award
2018
Program Status
Inactive
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

2225 West Harrison Street Suite F
Chicago, IL 60612
   (312) 997-2150
   info@zuchem.com
   www.zuchem.com
Location: Multiple
Congr. District: 07
County: Cook

Public Profile

zuChem Inc. manufactures and markets glycochemicals for the food, fine chemicals, and pharmaceutical intermediates industries. The company’s glycochemicals are components of drugs and drug candidates, as well as specialty food ingredients. The firm's products and services include sugar polyols, which are alternative sweeteners produced from natural raw materials by chemical hydrogenation; bioprocess development and engineering; custom chemical synthesis services; and sugar reagents.

Extent of SBIR involvement

User Avatar
Phase I Awards
10
Phase II Awards
6
Conversion Rate
60.00%
Phase I Dollars
$1,338,987
Phase II Dollars
$5,378,809
Total Awarded
$6,717,796

Synopsis: Awardee Business Condition

Employee Range
15-19
Revenue Range
1M-1.5M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
5-9

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2018 1 NIH $147,325
Project Title: Integrated System for Rapid Production of Activated Sugars and Glycosylated Molecules
2016 2 NIH $1,462,553
Project Title: High-Yield Production of GDP-Fucose for Fucosylation of Molecules
2016 1 NIH $175,813
Project Title: Engineered Aldolase for the Fermentative Production of L-Fucose and Other Rare Sugars.
2015 2 NIH $1,235,242
Project Title: Production of Activated Tdp-Deoxysugars in E. Coli
2014 1 NIH $168,163
Project Title: Activated Hexosamines from Chitin for Production of Important Oligosaccharides

Key People / Management

  David Demirjian -- Chief Executive Officer, President and Director,

  Rajni Aneja -- Vice President of Corporate Development

  Grant Brewen -- Board of Directors

  Thomas Churchwell -- Board of Directors

  Daniel M Cummings -- Chief Operating Officer and General Counsel

  David R Dodds

  Nelson Levy -- Board of Directors

  Jim McConoughey -- Board of Directors

  Michael Racine -- Director of Fermentation Technology

  Mike Racine

  Micah Shepherd

  Douglas Stewart -- Board of Directors

  Jeffrey A Whitnell -- Chief Financial Officer

  Ryan Woodyer -- Senior Scientist of Molecular Biology,

  Nathan J Wymer

Company News

Jan 21 2014
zuChem Enters into Exclusive License for Rights to 2'-FL Production Technology
Sep 09 2013
Zuchem Expands Rare Sugar Product Offerings